Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
“…deaths from cardiovascular disease among cancer patients…has shown that more than one in ten cancer patients do not die from their cancer but from heart and blood vessel problems instead…” The
Continue reading“Eight of 10 pediatric cancer survivors had abnormal findings on brain, heart, and bone images, including six patients with and two patients without clinical symptoms.” Though the study linked
Continue readingI am a long-term multiple myeloma (MM) survivor. I live with several long-term treatment-related side effects. As such I work hard to maintain my health. Nutrition is a crucial part of fitness according
Continue readingStandard-risk patients should never be undertreated, as they derive the highest relative benefit from using the best available registered therapies. (Oncology and I disagree…) Hi David – I
Continue readingMy name is David Emerson. I am a long-term survivor of an incurable blood cancer called multiple myeloma. I can tell you without a doubt that the lifestyle changes outlined below are central to how I have
Continue readingSteroid-induced shoulder avascular or osteonecrosis is one of a string of long-term and late stage side effects that occurred during the years after my conventional therapies following my multiple myeloma
Continue reading“…our findings offer strong support for the view that in some individuals, monoclonal gammopathy has the potential to cause systemic disease resulting in wide-ranging organ/tissue damage and
Continue reading“…plasma cell proliferation results in a solitary lesion (solitary bone plasmacytoma or extramedullary plasmacytoma…acute cauda equina syndrome (CES) secondary to solitary bone plasmacytoma
Continue readingAccording to research 95% of all MM is diagnosed at stage 2 or 3, that is to say advanced. MM is difficult to see coming. Therefore stabilizing MM patients is oncology’s priority. The standard-of-care
Continue reading“The increased risk of multiple myeloma (MM) in relatives of individuals with MGUS is consistent with MGUS being a marker of inherited genetic susceptibility to MM…” You or a family-member has
Continue reading“Renal Impairment represents an independent negative prognostic factor in MM…Renal recovery and haematologic response are the strongest markers associated with patient survival… Targeting
Continue reading“The frequency of second primary malignancies was higher in patients in the treatment group than in those in the observation group (six of 63 patients)..” Early or deferred treatment of smoldering
Continue reading